By the time Moderna and Pfizer apply to the FDA, vaccine efficacy data will be even clearer

By the time Moderna and Pfizer apply to the US Food and Drug Administration for authorization for their coronavirus vaccines, there will likely be even more data to show how well the vaccines work, according to two doctors involved with the process. ¬†On Monday, Pfizer announced that 94 participants in their Phase 3 clinical trial … Continue reading By the time Moderna and Pfizer apply to the FDA, vaccine efficacy data will be even clearer